Holly Reeves

Holly is the market leader for the PwC US Health Industries Emerging Company Solutions practice. With extensive experience working with venture-backed organizations, she has guided them through the process of starting operations, completing initial public offerings, and transitioning into commercial public companies. Holly brings leading insights, methodology, and technical experience, including relevant IPO experience.

Holly has been involved with a wide variety of business and financial reporting issues, including internal controls, mergers and acquisitions, collaborations, revenue recognition, commercial product launches, accounting for equity instruments, and stock-based compensation. She also has significant experience dealing with SEC reporting matters and has assisted numerous venture-backed biotechs with their initial public offering.

As a recognized subject matter specialist in the pharmaceuticals and life sciences industry, Holly supports PwC’s client service teams nationwide by sharing her deep industry experience and offering practical solutions based on thoughtful analysis. She is also a frequent presenter at seminars.